PCN7 COMPARATIVE EFFECTIVENESS ASSESSMENT OF ERLOTINIB VERSUS GEFITINIB IN FIRST-LINE EGFR ACTIVATING MUTATION POSITIVE NON-SMALL CELL LUNG CANCER
Abstract
Authors
B. Schwander J. de Castro Carpeño D.F. Heigener E. Wright H.G. Bischoff S. Walzer